Genetic landscape of human papillomavirus-associated head and neck cancer and comparison to tobacco-related tumors

D. Neil Hayes, Carter Van Waes, Tanguy Y. Seiwert

Research output: Contribution to journalReview articlepeer-review

Abstract

Head and neck cancer is the fifth most common cancer worldwide. It is often amenable to curative intent therapy when localized to the head and neck region, but it carries a poor prognosis when it is recurrent or metastatic. Therefore, initial treatment decisions are critical to improve patient survival. However, multimodality therapy used with curative intent is toxic. The balance between offering intensive versus tolerable and function-preserving therapy has been thrown into sharp relief with the recently described epidemic of human papillomavirus-associated head and neck squamous cell carcinomas characterized by improved clinical outcomes compared with smokingassociated head and neck tumors. Model systems and clinical trials have been slow to address the clinical questions that face the field to date. With this as a background, a host of translational studies have recently reported the somatic alterations in head and neck cancer and have highlighted the distinct genetic and biologic differences between viral and tobacco-associated tumors. This review seeks to summarize the main findings of studies, including The Cancer Genome Atlas, for the clinician scientist, with a goal of leveraging this new knowledge toward the betterment of patients with head and neck cancer.

Original languageEnglish (US)
Pages (from-to)3227-3234
Number of pages8
JournalJournal of Clinical Oncology
Volume33
Issue number29
DOIs
StatePublished - Oct 10 2015
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Genetic landscape of human papillomavirus-associated head and neck cancer and comparison to tobacco-related tumors'. Together they form a unique fingerprint.

Cite this